Deborah D. Opiekun's most recent trade in Leidos Holdings Inc was a trade of 18 Common Stock done . Disclosure was reported to the exchange on Dec. 29, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leidos | D. Deborah Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 18 | 6,834 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.52 per share. | 10 Nov 2023 | 58 | 6,816 (0%) | 0% | 102.5 | 5,946 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 20 | 6,874 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.10 per share. | 07 Aug 2023 | 96 | 10,629 (0%) | 0% | 97.1 | 9,322 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 21 | 6,854 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 20 | 6,833 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.51 per share. | 08 Mar 2023 | 70 | 10,624 (0%) | 0% | 96.5 | 6,756 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 7,066 | 7,066 | - | - | Stock Option (Right to Buy) | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 1,869 | 6,824 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.30 per share. | 03 Mar 2023 | 47 | 10,735 (0%) | 0% | 97.3 | 4,573 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.29 per share. | 03 Mar 2023 | 41 | 10,694 (0%) | 0% | 97.3 | 3,989 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.30 per share. | 03 Mar 2023 | 20 | 6,804 (0%) | 0% | 97.3 | 1,946 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 8 | 6,813 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 2,249 | 4,954 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 838 | 11,106 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.96 per share. | 09 Feb 2023 | 324 | 10,782 (0%) | 0% | 99.0 | 32,063 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 9 | 2,705 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.24 per share. | 11 Nov 2022 | 72 | 10,242 (0%) | 0% | 107.2 | 7,721 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 10 | 2,696 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.55 per share. | 06 Aug 2022 | 116 | 10,284 (0%) | 0% | 100.6 | 11,664 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 9 | 2,685 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 8 | 2,675 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.86 per share. | 08 Mar 2022 | 77 | 10,356 (0%) | 0% | 106.9 | 8,228 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.70 per share. | 04 Mar 2022 | 57 | 10,481 (0%) | 0% | 107.7 | 6,139 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.71 per share. | 04 Mar 2022 | 48 | 10,433 (0%) | 0% | 107.7 | 5,170 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.76 per share. | 02 Mar 2022 | 54 | 10,538 (0%) | 0% | 104.8 | 5,657 | Common Stock |
| Leidos | Deborah D. Opiekun | Chief Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,993 | 11,183 (0%) | 0% | 0 | Common Stock | |
| Leidos | Deborah D. Opiekun | Chief Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.43 per share. | 10 Feb 2022 | 591 | 10,592 (0%) | 0% | 88.4 | 52,262 | Common Stock |